Skip to main content
Clinical Trials/NCT06372860
NCT06372860
Completed
N/A

Diabetes Prevention Program Feasibility Study of Breastfeeding - Electronic Monitoring of Mom's Schedule 2.0

University of Kansas Medical Center1 site in 1 country43 target enrollmentApril 30, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Overweight or Obesity
Sponsor
University of Kansas Medical Center
Enrollment
43
Locations
1
Primary Endpoint
Duration of Lactation
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The purpose of this study is to investigate the impact of a comprehensive intervention that combines breastfeeding support with a diabetes prevention-based program (DPP) on postpartum weight retention and lactation duration among women with pre-pregnancy overweight or obesity. This intervention, named eMOMS, is delivered by a certified health coach via a mobile health (mHealth) application.

Detailed Description

This study is a randomized controlled trial designed to determine the feasibility and efficacy of a combined breastfeeding, diabetes prevention-based program (DPP) in a cohort of overweight or obese women to be followed during pregnancy through 3 months postpartum. The trial will have two study arms: DPP + breastfeeding (Tx1) and Usual Care (Tx2). Aim 1: Quantify interest in use of the DPP-lactation mobile health (mHealth) application among target population. To accomplish this, we will: (1) measure research engagement including rates of screening, recruitment, and retention among users, especially rural and racially/ethnically diverse women; (2) assess barriers/facilitators to enrollment/retention through surveys and semi-structured in-depth interviews or focus groups; and (3) evaluate intervention uptake, delivery, and adherence via tracking/measuring use of the mHealth app. Aim 2: Measure weight loss and duration of lactation through 3 months postpartum among target population. To accomplish this, we will measure pre-pregnancy weight, weight at study entry, weight immediately prior to and after delivery, and weight at specific postpartum time points. Lactation and infant feeding practices will be measured at similar postpartum time points.

Registry
clinicaltrials.gov
Start Date
April 30, 2024
End Date
August 31, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lisette Jacobson

Associate Professor, Population Health

University of Kansas Medical Center

Eligibility Criteria

Inclusion Criteria

  • In second trimester or early third trimester
  • BMI \>/= 25 and \< 35
  • At least 18 years old or older
  • Able to read and understand English
  • Able to learn and use a video platform

Exclusion Criteria

  • Complications related to pregnancy that require emergency care
  • Thyroid disease
  • Multiple gestation
  • Substance abuse within last 3 years
  • Assisted reproductive technology (ART)-related pregnancy
  • Current smoker
  • Prior bariatric surgery
  • In weight-loss program within 3 months of conception
  • BMI \>/= 35
  • Unable to attend intervention/ follow-up visits

Outcomes

Primary Outcomes

Duration of Lactation

Time Frame: At delivery, discharge, at day 7, week 3, 6, month 1, 2, and 3 postpartum.

The study team will measure duration of maternal ability to breastfeed at specific timepoints.

Maternal body mass index (BMI)

Time Frame: At baseline; at week 30, 32, and 34 of pregnancy; and at day 3, 10, week 3, 6, month 2 and month 3 postpartum.

Body mass index (BMI) is a measure of body fat based on height and weight. The study team will measure BMI and to allow for meaningful comparisons of weight change among study arms.

Maternal weight

Time Frame: At baseline; at week 30, 32, and 34 of pregnancy; and at day 3, 10, week 3, 6, month 2 and month 3 postpartum.

The study team will measure maternal weight to calculate maternal BMI and to allow for meaningful comparisons of weight change among study arms.

Initiation of Lactation

Time Frame: At delivery.

The study team will assess whether (yes/no) lactation was initiated at birth.

Type of Infant Feeding

Time Frame: At delivery, discharge, at day 7, week 3, 6, month 1, 2, and 3 postpartum.

The study team will measure "exclusive" lactation (human milk only) versus "any" lactation (predominant human milk with formula or solid food supplementation) at specific timepoints.

Secondary Outcomes

  • Retention Rate(This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.)
  • Mobile Application Usage(This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.)
  • Recruitment Rate(This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.)
  • Health Coach Interaction(This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.)
  • Research Engagement(After week 36 of pregnancy but prior to delivery, and after month 3 postpartum.)

Study Sites (1)

Loading locations...

Similar Trials